Efficacy and Safety Profile of Diclofenac/Cyclodextrin and Progesterone/Cyclodextrin Formulations: A Review of the Literature Data-Reference-Cited by-同舟云学术

Efficacy and Safety Profile of Diclofenac/Cyclodextrin and Progesterone/Cyclodextrin Formulations: A Review of the Literature Data

Published:2016-03-03 Issue:2 Volume:16 Page:129-140
ISSN:1174-5886
Container-title:Drugs in R&D
language:en
Short-container-title:Drugs R D

Author:

Scavone Cristina,Bonagura Angela Colomba,Fiorentino Sonia,Cimmaruta Daniela,Cenami Rosina,Torella Marco,Fossati Tiziano,Rossi Francesco

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology

Link

http://link.springer.com/content/pdf/10.1007/s40268-016-0123-2.pdf

Reference64 articles.

1. Guidance for Industry. Waiver of in vivo bioavailability and bioequivalence studies for immediate-release solid oral dosage forms based on a biopharmaceutics classification system. US Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER). August 2000 BP. Available at: http://www.fda.gov/downloads/Drugs/…/Guidances/ucm070246.pdf . Accessed 14 Jan 2016.

2. Kumar S, Bhargava D, Thakkar A, Arora S. Drug carrier systems for solubility enhancement of BCS class II drugs: a critical review. Crit Rev Ther Drug Carrier Syst. 2013;30:217–56.

3. Gidwani B, Vyas A. Synthesis, characterization and application of epichlorohydrin-β-cyclodextrin polymer. Colloids Surf B Biointerfaces. 2014;114:130–7.

4. Loftsson T, Duchêne D. Cyclodextrins and their pharmaceutical applications. Int J Pharm. 2007;329:1–11.

5. Tiwari G, Tiwari R, Rai AK. Cyclodextrins in delivery systems: applications. J Pharm Bioallied Sci. 2010;2:72–9.

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Improving the Solubility and Bioavailability of Progesterone Cocrystals with Selected Carboxylic Acids;Pharmaceutics;2024-06-16

2. Controlling the Solubility, Release Rate and Permeation of Riluzole with Cyclodextrins;Pharmaceutics;2024-06-03

3. Therapeutic potential of procathepsin L-inhibiting and progesterone-entrapping dimethyl-β-cyclodextrin nanoparticles in treating experimental sepsis;Frontiers in Immunology;2024-03-14

4. Cyclodextrins and derivatives in drug delivery: New developments, relevant clinical trials, and advanced products;Carbohydrate Polymers;2024-01

5. Comparative study on the effects of the inclusion complexes of non-steroidal anti-inflammatory drugs with 2-hydroxypropyl-β-cyclodextrins on dissociation rates and supersaturation;RSC Pharmaceutics;2024